Lifeward (LFWD) Revenue Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -22.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.07% |
| Dec 31, 2025 | -32.66% |
| Sep 30, 2025 | 1.09% |
| Jun 30, 2025 | -14.66% |
| Mar 31, 2025 | -4.71% |
| Dec 31, 2024 | 9.60% |
| Sep 30, 2024 | 39.18% |
| Jun 30, 2024 | 401.65% |
| Mar 31, 2024 | 329.51% |
| Dec 31, 2023 | 215.92% |
| Sep 30, 2023 | 396.95% |
| Jun 30, 2023 | -14.84% |
| Mar 31, 2023 | 40.41% |
| Dec 31, 2022 | 75.44% |
| Sep 30, 2022 | -55.07% |
| Jun 30, 2022 | 9.33% |
| Mar 31, 2022 | -33.43% |
| Dec 31, 2021 | 1.97% |
| Sep 30, 2021 | 163.99% |
| Jun 30, 2021 | -13.91% |
| Mar 31, 2021 | 73.16% |
| Dec 31, 2020 | 3.13% |
| Sep 30, 2020 | -39.47% |
| Jun 30, 2020 | 90.19% |
| Mar 31, 2020 | -51.93% |
| Dec 31, 2019 | -25.21% |
| Sep 30, 2019 | -23.69% |
| Jun 30, 2019 | -50.45% |
| Mar 31, 2019 | 0.13% |
| Dec 31, 2018 | 4.22% |
| Sep 30, 2018 | -6.64% |
| Jun 30, 2018 | -11.81% |
| Mar 31, 2018 | -36.81% |
| Dec 31, 2017 | -4.78% |
| Sep 30, 2017 | 23.71% |
| Jun 30, 2017 | 145.65% |
| Mar 31, 2017 | 21.25% |
| Dec 31, 2016 | 19.09% |
| Sep 30, 2016 | 20.17% |
| Jun 30, 2016 | 33.93% |
| Mar 31, 2016 | 224.57% |
| Dec 31, 2015 | -8.87% |
| Sep 30, 2015 | -24.35% |
| Jun 30, 2015 | 22.00% |
| Dec 31, 2014 | 282.77% |
| Sep 30, 2014 | 277.45% |